Time To Take Profits On Gilead Sciences (Rating Downgrade)
Source: SeekingAlpha
2026-02-20 14:24:17 ET
Shares of Gilead Sciences, Inc. ( GILD ), my favorite in the HIV drugs market, have risen 23.3% since my previous article , " Gilead Sciences: From All-Time Highs To Higher Highs. "...
Read the full article on Seeking Alpha
For further details see:
Time To Take Profits On Gilead Sciences (Rating Downgrade)
Genfit
NASDAQ: GNFTF
GNFTF Trading
-16.98% G/L:
$7.87 Last:
1,000 Volume:
$9.48 Open:
GNFTF Latest News
March 09, 2026 01:00:00 pm
GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF
February 26, 2026 12:00:00 pm
GENFIT Reports Fourth Quarter 2025 Financial Information and Provides a Corporate Update
GNFTF Stock Data
$361,801,977
47,868,958
N/A
30
N/A
Biotechnology & Life Sciences
Healthcare
FR
Loos
